In mouse models of stomach adenocarcinoma (STAD), FAP-positive CAFs significantly contribute to cell proliferation and exhibit reduced sensitivity to anti-PD1 therapy [9]. This evidence concerns the gene FAP and gastric adenocarcinoma.